DRAXIS RENEWS PRODUCTION AGREEMENT WITH PFIZER CONSUMER HEALTHCARE CANADA

DRAXIS Health Inc. (TSX: DAX)(Nasdaq: DRAX) has renewed the production outsourcing agreement between its contract manufacturing division and Pfizer Canada Inc., Pfizer Consumer Healthcare division. The new 3-year manufacturing and supply agreement is effective as of January 1, 2005. DRAXIS Pharma, a division of DRAXIS Specialty Pharmaceuticals Inc., will continue to produce several non-prescription products as one of a select number of approved suppliers to Pfizer Consumer Healthcare Canada.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-01-2005/0004098076&EDATE=)